RFA for early esophageal neoplasia

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

The primary goal of endoscopic therapy for Barrett's esophagus (BE) with early esophageal neoplasia is to achieve complete eradication of the cancer and, for best long-term results, complete remission of the intestinal metaplasia (CR-IM). Radio frequency ablation (RFA) has become the mucosal ablation technique of choice, because of its improved side-effect profile and improvement in treatment efficiency. RFA is a thermal ablative modality that uses alternating electrical current to generate an electromagnetic field, which causes charged ions to rapidly oscillate and release thermal energy. Although surveillance biopsies are not included in the treatment protocol for RFA, it is proposed that failure to respond to RFA be defined by lack of improvement in the BE segment area and grade of dysplasia after two RFA sessions. Early esophageal neoplasia often presents with endoscopically visible mucosal irregularities (nodules) that can be targeted with endoscopic mucosal resection (EMR).

Original languageEnglish (US)
Title of host publicationEsophageal Cancer and Barrett's Esophagus
PublisherWiley Blackwell
Pages151-160
Number of pages10
ISBN (Electronic)9781118655153
ISBN (Print)9781118655207
DOIs
StatePublished - Dec 12 2015

Fingerprint

Radio
Barrett Esophagus
Neoplasms
Hot Temperature
Ablation Techniques
Electromagnetic Fields
Metaplasia
Clinical Protocols
Ions
Biopsy
Therapeutics

Keywords

  • Barrett's esophagus
  • Endoscopic mucosal resection
  • Esophageal neoplasia
  • Radio frequency ablation
  • Subsquamous intestinal metaplasia

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Chan, D. K., Leggett, C., & Wang, K. K. N. (2015). RFA for early esophageal neoplasia. In Esophageal Cancer and Barrett's Esophagus (pp. 151-160). Wiley Blackwell. https://doi.org/10.1002/9781118655153.ch16

RFA for early esophageal neoplasia. / Chan, Daniel K.; Leggett, Cadman; Wang, Kenneth Ke Ning.

Esophageal Cancer and Barrett's Esophagus. Wiley Blackwell, 2015. p. 151-160.

Research output: Chapter in Book/Report/Conference proceedingChapter

Chan, DK, Leggett, C & Wang, KKN 2015, RFA for early esophageal neoplasia. in Esophageal Cancer and Barrett's Esophagus. Wiley Blackwell, pp. 151-160. https://doi.org/10.1002/9781118655153.ch16
Chan DK, Leggett C, Wang KKN. RFA for early esophageal neoplasia. In Esophageal Cancer and Barrett's Esophagus. Wiley Blackwell. 2015. p. 151-160 https://doi.org/10.1002/9781118655153.ch16
Chan, Daniel K. ; Leggett, Cadman ; Wang, Kenneth Ke Ning. / RFA for early esophageal neoplasia. Esophageal Cancer and Barrett's Esophagus. Wiley Blackwell, 2015. pp. 151-160
@inbook{a4194643a0a04f9a9fb50b9cd56ffdeb,
title = "RFA for early esophageal neoplasia",
abstract = "The primary goal of endoscopic therapy for Barrett's esophagus (BE) with early esophageal neoplasia is to achieve complete eradication of the cancer and, for best long-term results, complete remission of the intestinal metaplasia (CR-IM). Radio frequency ablation (RFA) has become the mucosal ablation technique of choice, because of its improved side-effect profile and improvement in treatment efficiency. RFA is a thermal ablative modality that uses alternating electrical current to generate an electromagnetic field, which causes charged ions to rapidly oscillate and release thermal energy. Although surveillance biopsies are not included in the treatment protocol for RFA, it is proposed that failure to respond to RFA be defined by lack of improvement in the BE segment area and grade of dysplasia after two RFA sessions. Early esophageal neoplasia often presents with endoscopically visible mucosal irregularities (nodules) that can be targeted with endoscopic mucosal resection (EMR).",
keywords = "Barrett's esophagus, Endoscopic mucosal resection, Esophageal neoplasia, Radio frequency ablation, Subsquamous intestinal metaplasia",
author = "Chan, {Daniel K.} and Cadman Leggett and Wang, {Kenneth Ke Ning}",
year = "2015",
month = "12",
day = "12",
doi = "10.1002/9781118655153.ch16",
language = "English (US)",
isbn = "9781118655207",
pages = "151--160",
booktitle = "Esophageal Cancer and Barrett's Esophagus",
publisher = "Wiley Blackwell",

}

TY - CHAP

T1 - RFA for early esophageal neoplasia

AU - Chan, Daniel K.

AU - Leggett, Cadman

AU - Wang, Kenneth Ke Ning

PY - 2015/12/12

Y1 - 2015/12/12

N2 - The primary goal of endoscopic therapy for Barrett's esophagus (BE) with early esophageal neoplasia is to achieve complete eradication of the cancer and, for best long-term results, complete remission of the intestinal metaplasia (CR-IM). Radio frequency ablation (RFA) has become the mucosal ablation technique of choice, because of its improved side-effect profile and improvement in treatment efficiency. RFA is a thermal ablative modality that uses alternating electrical current to generate an electromagnetic field, which causes charged ions to rapidly oscillate and release thermal energy. Although surveillance biopsies are not included in the treatment protocol for RFA, it is proposed that failure to respond to RFA be defined by lack of improvement in the BE segment area and grade of dysplasia after two RFA sessions. Early esophageal neoplasia often presents with endoscopically visible mucosal irregularities (nodules) that can be targeted with endoscopic mucosal resection (EMR).

AB - The primary goal of endoscopic therapy for Barrett's esophagus (BE) with early esophageal neoplasia is to achieve complete eradication of the cancer and, for best long-term results, complete remission of the intestinal metaplasia (CR-IM). Radio frequency ablation (RFA) has become the mucosal ablation technique of choice, because of its improved side-effect profile and improvement in treatment efficiency. RFA is a thermal ablative modality that uses alternating electrical current to generate an electromagnetic field, which causes charged ions to rapidly oscillate and release thermal energy. Although surveillance biopsies are not included in the treatment protocol for RFA, it is proposed that failure to respond to RFA be defined by lack of improvement in the BE segment area and grade of dysplasia after two RFA sessions. Early esophageal neoplasia often presents with endoscopically visible mucosal irregularities (nodules) that can be targeted with endoscopic mucosal resection (EMR).

KW - Barrett's esophagus

KW - Endoscopic mucosal resection

KW - Esophageal neoplasia

KW - Radio frequency ablation

KW - Subsquamous intestinal metaplasia

UR - http://www.scopus.com/inward/record.url?scp=84976901281&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84976901281&partnerID=8YFLogxK

U2 - 10.1002/9781118655153.ch16

DO - 10.1002/9781118655153.ch16

M3 - Chapter

SN - 9781118655207

SP - 151

EP - 160

BT - Esophageal Cancer and Barrett's Esophagus

PB - Wiley Blackwell

ER -